Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY)

Price 6.50p on 02-01-2025 at 17:30:02
Change 0.30p 4.62%
Buy 7.00p
Sell 6.00p
Buy / Sell AGY Shares
Last Trade: Buy 60,000.00 at 6.80p
Day's Volume: 235,649
Last Close: 6.80p
Open: 6.66p
ISIN: GB00B02LCQ05
Day's Range 6.50p - 7.00p
52wk Range: 1.95p - 7.00p
Market Capitalisation: £324m
VWAP: 6.850314p
Shares in Issue: 4,767m

Recent Trades History Allergy Thera. (AGY)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 60,000 6.80p Suspected BUY Trade
16:35:25 - 02-Jan-25
Buy* 7,000 6.66p Ordinary
16:23:27 - 02-Jan-25
Buy* 30,000 6.90p Suspected BUY Trade
14:00:22 - 02-Jan-25
Buy* 20,000 6.66p Ordinary
12:21:43 - 02-Jan-25
Buy* 72,567 6.875p Ordinary
11:33:05 - 02-Jan-25
Buy* 261 6.525p Ordinary
11:25:05 - 02-Jan-25
Buy* 20,000 7.00p Suspected BUY Trade
11:00:07 - 02-Jan-25
Sell* 20 6.00p SI Trade
09:10:03 - 02-Jan-25
Sell* 177 6.00p SI Trade
09:10:03 - 02-Jan-25
Buy* 17,948 7.00p Suspected BUY Trade
09:00:14 - 02-Jan-25

Share Price History for Allergy Thera.

Time period:
to
Date Open High Low Close Volume

Share News for Allergy Thera.

UK shareholder meetings calendar - next 7 days

9th Dec 2024 11:30

Read More

IN BRIEF: Allergy Therapeutics treats first patient in allergy trial

27th Nov 2024 16:52

Allergy Therapeutics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric trial of Grass Mata MPL. The trial aims to evaluate the long-term efficacy and safety of the drug in treating children with grass pollen allergies. The drug was trialled in adults last year, and showed a "highly statistically significant reduction in the combined symptom and medication score". Grass Mata MPL addresses the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen, and works to modify the body's allergic response in as few as six injections ahead of the allergy season. Read More

LONDON MARKET MIDDAY: Stocks up after Donald Trump's shock victory

6th Nov 2024 12:08

(Alliance News) - Stock prices in London remained higher at midday on Wednesday as markets digested the surprisingly speedy news that Donald Trump, along with policies likely to stoke higher inflation, will be re-entering the White House. Read More

Allergy Therapeutics annual loss narrows thanks to reduced expenses

6th Nov 2024 11:22

(Alliance News) - Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decline in revenue, as it reduced administrative expenses. Read More

Allergy Therapeutics shares surge as enters into secured loan facility

16th Oct 2024 10:58

(Alliance News) - Allergy Therapeutics PLC shares rallied on Wednesday after it announced a funding update with an alternative asset management firm. Read More

FTSE 100 Latest
Value8,260.09
Change87.07

Login to your account

Forgot Password?

Not Registered